The output of Austria’s Basic Pharmaceutical Products and Preparations Manufacturing has demonstrated a steady upward trajectory from 2013 to 2023, standing at 5.42 billion Euros in 2023. Over the past decade, key fluctuations included a notable increase in 2019 (10.27% year-on-year) and a decrease in 2021 (-0.64% year-on-year). The most recent data indicates a year-on-year growth of 2.09% for 2023 with a 5-year CAGR of 3.46%, showcasing consistent moderate growth.
Looking ahead, the forecast until 2028 suggests continued growth with an average annual growth rate (CAGR) of 1.85%. The sector is projected to reach 6.09 billion Euros by 2028, indicating a total growth rate of 9.57% over the next five years.
Future trends to watch for include:
- The impact of technological advancements and digital transformation on production efficiency.
- Regulatory changes in the pharmaceutical industry within the EU.
- The influence of global health trends and emergent diseases on pharmaceutical demand.
